754 related articles for article (PubMed ID: 16247563)
21. Age of onset of substance use and psychosocial problems among individuals with substance use disorders.
Poudel A; Gautam S
BMC Psychiatry; 2017 Jan; 17(1):10. PubMed ID: 28077106
[TBL] [Abstract][Full Text] [Related]
22. Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review.
Prat G; Marquez-Arrico JE; Río-Martínez L; Navarro JF; Adan A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110310. PubMed ID: 33775743
[TBL] [Abstract][Full Text] [Related]
23. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
24. Correlates of mental health service use intensity in the National Comorbidity Survey and National Comorbidity Survey Replication.
Elhai JD; Ford JD
Psychiatr Serv; 2007 Aug; 58(8):1108-15. PubMed ID: 17664523
[TBL] [Abstract][Full Text] [Related]
25. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
[TBL] [Abstract][Full Text] [Related]
26. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients.
Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Lipp O; Stip E; Potvin S
Psychiatry Res; 2012 Dec; 200(2-3):237-41. PubMed ID: 22980481
[TBL] [Abstract][Full Text] [Related]
27. The consequences of Conduct Disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services.
Hodgins S; Tiihonen J; Ross D
Schizophr Res; 2005 Oct; 78(2-3):323-35. PubMed ID: 15996855
[TBL] [Abstract][Full Text] [Related]
28. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders.
Dumais A; Potvin S; Joyal C; Allaire JF; Stip E; Lesage A; Gobbi G; Côté G
Schizophr Res; 2011 Aug; 130(1-3):234-7. PubMed ID: 21441016
[TBL] [Abstract][Full Text] [Related]
29. Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
Sara G; Burgess P; Harris M; Malhi GS; Whiteford H; Hall W
Aust N Z J Psychiatry; 2012 Dec; 46(12):1173-81. PubMed ID: 22990432
[TBL] [Abstract][Full Text] [Related]
30. Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review.
Adan A; Arredondo AY; Capella MD; Prat G; Forero DA; Navarro JF
Neurosci Biobehav Rev; 2017 Apr; 75():361-377. PubMed ID: 28188887
[TBL] [Abstract][Full Text] [Related]
31. A national study of violent behavior in persons with schizophrenia.
Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
[TBL] [Abstract][Full Text] [Related]
32. Differences in substance use, psychiatric disorders and social factors between Mexican adolescents and young adults.
Tejeda-Romero C; Kobashi-Margáin RA; Alvarez-Arellano L; Corona JC; González-García N
Am J Addict; 2018 Dec; 27(8):625-631. PubMed ID: 30265430
[TBL] [Abstract][Full Text] [Related]
33. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
[TBL] [Abstract][Full Text] [Related]
34. Self-medication of mental health problems: new evidence from a national survey.
Harris KM; Edlund MJ
Health Serv Res; 2005 Feb; 40(1):117-34. PubMed ID: 15663705
[TBL] [Abstract][Full Text] [Related]
35. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.
Bhalla IP; Stefanovics EA; Rosenheck RA
Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S24-S32. PubMed ID: 28806363
[TBL] [Abstract][Full Text] [Related]
36. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice.
West JC; Wilk JE; Olfson M; Rae DS; Marcus S; Narrow WE; Pincus HA; Regier DA
Psychiatr Serv; 2005 Mar; 56(3):283-91. PubMed ID: 15746502
[TBL] [Abstract][Full Text] [Related]
37. Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis.
Gonzalez VM; Bradizza CM; Vincent PC; Stasiewicz PR; Paas ND
Addict Behav; 2007 Mar; 32(3):477-90. PubMed ID: 16828977
[TBL] [Abstract][Full Text] [Related]
38. Substance use disorders increase the odds of subsequent mood disorders.
Kenneson A; Funderburk JS; Maisto SA
Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
[TBL] [Abstract][Full Text] [Related]
39. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
Havassy BE; Arns PG
Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
[TBL] [Abstract][Full Text] [Related]
40. Clinical diagnosis of substance use disorders in private psychiatric populations.
Miller NS; Belkin BM; Gibbons R
J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]